मैट्रिक्स
 
 
साम्या बायोटेक इंडिया > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का साम्या बायोटेक इंडिया - बीएसई: 532905, NSE: N.A

साम्या बायोटेक इंडिया

बीएसई: 532905  |  NSE: N.A  |  ISIN: INE320H01019  |  Pharmaceuticals

कंपनी इतिहास - साम्या बायोटेक इंडिया
Our Company was incorporated as a Public Limited Company on August 13,
 2002 and certificate of commencement of  business was issued on August
 26, 2002 with the primary 
 objective to carry on the business of manufacture, buy,  import,
 export and generally deal in all types of chemicals, 
 pharmaceuticals,drugs and intermediates.Presently our  Company is not
 undertaking any activity.
 
 The registered office of our Company is situated at 104-106 Lumbini
 Enclave, Punjagutta, Hyderabad-500082
 
 Our Company proposes to set up manufacturing facility in Shapoorji
 Pallonji Biotech Park Pvt Ltd, at plotNo 10, Kolthur  village
 Shameerpet Mandal, Rangareddy District, Andhra Pradesh
 to manufacture low volume high value active Bio-Pharmaceutical
 ingredients viz., Daunomycin (anti-cancer), Hyaluronic Acid  Pharma
 Grade (Ophthalmic medicine) and Cosmetic Grade.
 
 Our Company has entered into technology transfer agreement with
 Biofin laboratories s.r.l Italy for Technology Know-How to
 manufacture Bio-Pharmaceutical ingredients.Our Company has 
 entered into sales and purchase agreement with M/s Finchimica, Italy
 on September 18,2004, in terms of which M/s Finchimica, Italy would
 buy all the products manufactured by us to the extent
 of 100%.
 
 The detailed engineering and for civil design (in accordance with the
 regulations of USFDA. and European drug standards) of the plant is
 being done by M/s. Shapoorji Pallonji and Company Ltd. Mumbai
 (SPCL).Our Company has already entered into an agreement with M/s.
 Shapoorji Pallonji and Company Ltd.
 
 2008
 
 -Company has created email id for grievance redressal division /
 compliance officer : info@saamyabiotech.com.
 
 2010
 
 -Company has entered into a Joint Venture Agreement with Perak Bio
 Corporation Sdn. Bhd. (PBC), a Company owned by Perak State Govt.,
 Malaysia to setup a bio-pharmaceutical manufacturing unit in Perak
 state for Saamya Biotech (Malaysia) Sdn. Bhd.,
 
 2011
 
 -Saamya Biotech (India) appointed Dr. Y Sonia Reddy as Chairman of
 the company.
 
 2014
 
 -Saamya Biotech (India) appointed Mr. Kishan Kumar Srishankar Jha  as
 Additional Director of the Company
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MS ON TITAN : Underweight रेटिंग, लक्ष्य `770/Sh
  • CLSA ON TITAN : Sell रेटिंग, लक्ष्य `855/Sh
  • MS ON SOBHA : Overweight रेटिंग, लक्ष्य `361/Sh

अभी देखें

मार्केट काउंटडाउन

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.